Shandong Xinhua Pharmaceutical Co Ltd (0719)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 5.510 |
|---|---|
| 52-week range | 5.029 – 7.418 |
| Return, 1 month / 3 months | +1.5% / −11.1% |
| Return, 1 year / 3 years | −20.1% / +11.8% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 32.1% |
| Worst drawdown (1 year) | -29.4% |
| Average daily value traded | 6.39M HKD |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Shandong Xinhua Pharmaceutical makes medicines and the chemical ingredients that go into them. The company produces analgesic and antipyretic ingredients, including paracetamol and aspirin, along with other pharmaceutical raw materials, and it turns these into finished forms such as tablets, capsules and injections. Its customers are drugmakers, distributors and healthcare providers in China and in export markets. The company is based in Zibo, in Shandong province, China.
Shandong Xinhua Pharmaceutical Co Ltd trades under the code 0719 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Shandong Xinhua Pharmaceutical Co Ltd (0719) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 5.510 on 20 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 793 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.1% and over the last three months it fell 11.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -10.0% | ||
| From 52-week high | -23.5% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.1% | ||
| 6-month return | -11.2% | ||
| 12-month return, skipping the last month | -21.2% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.4% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 6.39M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.4% |
|---|---|
| 1 month | +1.5% |
| 3 months | −11.1% |
| 6 months | −11.2% |
| 1 year | −20.1% |
| 3 years | +11.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 5.724 / 6.121 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.187 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Jul 2026 | HKD 0.1725 |
| 27 Jun 2025 | HKD 0.2731 |
| 4 Sep 2024 | HKD 0.0273 |
| 10 Jul 2024 | HKD 0.2741 |
| 7 Jul 2023 | HKD 0.2189 |
| 15 Jul 2022 | HKD 0.1758 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.